Related Experiment Video
Updated: May 23, 2026

A Novel Use of Three-dimensional High-frequency Ultrasonography for Early Pregnancy Characterization in the Mouse
Published on: October 24, 2017
Prediction and prevention of the macrosomic fetus
Jennifer M Walsh1, Fionnuala M McAuliffe
1UCD Obstetrics and Gynaecology, School of Medicine and Medical Science, University College Dublin, National Maternity Hospital, Dublin, Ireland. jennifer.walsh@ucd.ie
Insights
Preventing fetal macrosomia is crucial to avoid long-term childhood obesity and adult metabolic complications. Early identification of at-risk pregnancies through improved biomarkers and intervention in maternal factors like weight and glycaemic control are key.
Area of Science:
- Obstetrics and Gynecology
- Neonatal Health
- Public Health
Background:
- Fetal macrosomia (large for gestational age) is linked to significant maternal and neonatal morbidity.
- Long-term risks include childhood obesity and adult cardiovascular/metabolic complications.
- The global rise in obesity makes preventing this cycle a pertinent issue.
Purpose of the Study:
- To review contemporary evidence on predicting and preventing fetal macrosomia.
- To highlight the challenges in antenatal detection and the need for improved methods.
- To emphasize the importance of identifying and intervening in modifiable risk factors.
Main Methods:
- Review of current literature on fetal macrosomia prediction and prevention.
- Discussion of sonographic detection limitations and emerging biomarkers.
- Analysis of risk factors amenable to intervention, including maternal weight, gestational weight gain, and glycaemic control.
Main Results:
- Accurate sonographic detection of fetal macrosomia remains challenging.
- Maternal factors like obesity, age, weight, gestational weight gain, and glycaemic control are critical risk factors.
- Emerging fetal adiposity markers and maternal serum biomarkers show promise for improved antenatal detection.
Conclusions:
- Accurate prediction and prevention of fetal macrosomia are essential to mitigate long-term health risks.
- Intervention in modifiable maternal factors offers the most promising prevention strategy.
- Further research is needed to optimize methods for maternal weight and glucose management.
Abstract:
Fetal macrosomia is associated with significant maternal and neonatal morbidity. In the long term, infants who are large for gestational age are more likely than other infants to be obese in childhood, adolescence and early adulthood, and are inherently at higher risk of cardiovascular and metabolic complications in adulthood. With over one billion adults in the world now overweight and more than 600 million clinically obese, preventing the vicious cycle effect of fetal macrosomia and childhood obesity is an increasingly pertinent issue. Fetal growth is determined by a complex interplay of various genetic and environmental influences. Consequently the prediction of pregnancies at risk of pathological overgrowth is difficult. Many risk factors for fetal macrosomia, such as maternal obesity and advanced maternal age, are also conversely associated with intrauterine growth restriction. Sonographic detection of fetal macrosomia is notoriously fraught with difficulties, with dozens of formulas for estimated fetal weight proposed but few with sufficient sensitivity to alter clinical practice. This calls into question policies of elective delivery based on projected estimated fetal weight cut-offs alone. More recently the identification of markers of fetal adiposity and maternal serum biomarkers are being investigated to improve the antenatal detection of the large for gestational age fetus. Prevention of fetal macrosomia is entirely dependent upon correct identification of those at risk. Maternal weight, gestational weight gain and glycaemic control are the risk factors for fetal macrosomia that are most amenable to intervention, and have potential maternal health benefits beyond pregnancy and childbirth. The ideal method of optimising maternal weight and glucose homeostasis is yet to be elucidated, though a number of promising advances are recently being reported. In this review we outline the contemporary evidence for the prediction and prevention of fetal macrosomia, which is indeed a contemporary dilemma.
Related Concept Videos
Teratogenicity
Development of the Oral Microbiota
